Titlebook: Nanomaterial-Based Drug Delivery Carriers for Cancer Therapy; Tao Feng,Yanli Zhao Book 2017 The Author(s) 2017 Biocompatible nanoparticles

只看該作者 · 發(fā)表于 2025-3-21 17:05:22

書目名稱Nanomaterial-Based Drug Delivery Carriers for Cancer Therapy影響因子(影響力)

書目名稱Nanomaterial-Based Drug Delivery Carriers for Cancer Therapy影響因子(影響力)學(xué)科排名

書目名稱Nanomaterial-Based Drug Delivery Carriers for Cancer Therapy網(wǎng)絡(luò)公開度

書目名稱Nanomaterial-Based Drug Delivery Carriers for Cancer Therapy網(wǎng)絡(luò)公開度學(xué)科排名

書目名稱Nanomaterial-Based Drug Delivery Carriers for Cancer Therapy被引頻次

書目名稱Nanomaterial-Based Drug Delivery Carriers for Cancer Therapy被引頻次學(xué)科排名

書目名稱Nanomaterial-Based Drug Delivery Carriers for Cancer Therapy年度引用

書目名稱Nanomaterial-Based Drug Delivery Carriers for Cancer Therapy年度引用學(xué)科排名

書目名稱Nanomaterial-Based Drug Delivery Carriers for Cancer Therapy讀者反饋

書目名稱Nanomaterial-Based Drug Delivery Carriers for Cancer Therapy讀者反饋學(xué)科排名

只看該作者 · 發(fā)表于 2025-3-21 20:46:23

Tao Feng,Yanli Zhaoand where we are today and how we arrived at this particular juncture, and thereby better to appreciate possible futures. “Lest We Forget:” these are iconic words in the English language, words that most people immediately understand as relating to the millions of young citizens who lost their lives

只看該作者 · 發(fā)表于 2025-3-22 04:02:52

只看該作者 · 發(fā)表于 2025-3-22 06:11:33

只看該作者 · 發(fā)表于 2025-3-22 09:03:35

只看該作者 · 發(fā)表于 2025-3-22 14:59:44

Current Status and Characteristics of Cancer,oduces the current status and causes of cancer, and the characteristics of cancer tissues including abnormal metabolism, abnormal vasculature, resistance to anti-proliferative growth factors (GFs), unlimited replicative potential, immune system activation and inflammation, and interstitial pressure.

只看該作者 · 發(fā)表于 2025-3-22 19:41:37

只看該作者 · 發(fā)表于 2025-3-23 00:00:10

Nanomaterial-Based Drug Delivery Carriers for Cancer Therapy,ution, by the utilization of the enhanced permeability and retention (EPR) effect or active targeting to alter the uptake mechanism. This chapter presents different types of nanomaterial-based drug delivery carriers for the cancer treatment, including organic, inorganic, and organic–inorganic hybrid

只看該作者 · 發(fā)表于 2025-3-23 04:34:02

只看該作者 · 發(fā)表于 2025-3-23 07:40:36

2191-530X herapy. It highlights that precisely designed nanomaterials will be the next-generation therapeutic agents for cancer treatment..978-981-10-3297-4978-981-10-3299-8Series ISSN 2191-530X Series E-ISSN 2191-5318

		自動(dòng)登錄	找回密碼
密碼			To register

關(guān)于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務(wù)流程	影響因子官網(wǎng)	吾愛論文網(wǎng)	大講堂	北京大學(xué)	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點(diǎn)評	投稿經(jīng)驗(yàn)總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學(xué)	Yale Uni.	Stanford Uni.
\|Archiver\|手機(jī)版\|小黑屋\| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-21 03:56
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved